Tacita Capital’s Cardinal Health CAH Stock Holding History

Tacita Capital’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-139	Closed	-$14K	–	218
2023 Q4	$14K	Buy	+139	New	+$13.8K	0.01%	191

Other funds holding CAH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Tacita Capital's CAH Position: Q1 2024 in Review

Tacita Capital sold out of Cardinal Health (CAH) in Q1 2024, closing a stake of 139 shares — an estimated $14K sold.

Tacita Capital first reported a position in CAH in Q4 2023 and held it in 1 quarter. The position peaked at $14K in Q4 2023. 1,057 funds tracked by Wall St. Rank hold CAH as of Q1 2024.

Tacita Capital reported no remaining Cardinal Health position as of Q1 2024 after selling out during the quarter.
Tacita Capital sold 139 Cardinal Health shares in Q1 2024, an estimated $14K.
Tacita Capital first reported a position in Cardinal Health in Q4 2023 and held it in 1 quarter.
Tacita Capital's Cardinal Health position peaked at $14K in Q4 2023.
1,057 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2024.

Based on Tacita Capital's 13F filing for Q1 2024, filed 14 May 2024.